Artifactual Hypocalcemia from Gadodiamide Interference
Clinical Laboratory · 2025
DOI: 10.7754/clin.lab.2025.250319 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Laboratory, 2025. Verfasst von Xiaoyan Zhang und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hypocalcemia, Artifacts, Contrast Media, Gadolinium DTPA.
Abstract (Originalsprache)
BACKGROUND: Gadolinium-based contrast agents (GBCAs), such as gadodiamide, are known to interfere with colorimetric calcium assays, leading to spurious hypocalcemia. This case highlights the importance of recognizing such interference to avoid unnecessary clinical interventions. METHODS: A 51-year-old woman presented with a critically low serum calcium level (1.44 mmol/L) detected during routine testing. Repeat testing 4 hours later showed normalization (2.12 mmol/L). Investigations ruled out preanalytical and analytical errors. RESULTS: The discrepancy was attributed to gadodiamide administration for MRI 24 hours prior to blood sampling. The agent's interaction with the methylthymol blue (MXB) reagent artificially lowered calcium measurements. No interventions were required. CONCLUSIONS: Laboratory-clinical collaboration is essential to identify GBCA-induced artifactual hypocalcemia. Education on blood draw timing and alternative assays (e.g., ion-selective electrodes) is critical.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Zhang, X., Xu, Q., & Han, J. (2025). Artifactual Hypocalcemia from Gadodiamide Interference. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2025.250319
Vancouver
Zhang X, Xu Q, Han J. Artifactual Hypocalcemia from Gadodiamide Interference. Clinical Laboratory. 2025. doi:10.7754/clin.lab.2025.250319
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaoyan and Xu, Qiongying and Han, Jiehua},
title = {Artifactual Hypocalcemia from Gadodiamide Interference},
journal = {Clinical Laboratory},
year = {2025},
doi = {10.7754/clin.lab.2025.250319}
}
EUVIMED